Literature DB >> 6129464

Antimicrobial resistance of Neisseria gonorrhoea in Bangkok: is single-drug treatment passé.

S Brown, T Warnnissorn, J Biddle, K Panikabutra, A Traisupa.   

Abstract

201 gonococcal isolates obtained from patients attending clinics in Bangkok were tested for in-vitro antimicrobial susceptibility. 42% of these isolates were penicillinase-producing Neisseria gonorrhoeae (PPNG); of the 116 isolates of non-PPNG 53% had a penicillin minimum inhibitory concentration (MIC) greater than or equal to 1 microgram/ml and the remainder had MIC greater than or equal to 0.06 microgram penicillin/ml. Similarly high in-vitro resistance was found for six of eight other antimicrobial agents tested. These high antimicrobial MICs reflect the difficulties encountered in selecting therapeutic agents for the control of gonorrhoea in Thailand. Single-drug treatment for gonorrhoea may no longer be effective in some settings. There is an urgent need to evaluate combination therapies appropriate to such settings.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6129464     DOI: 10.1016/s0140-6736(82)91271-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

1.  Sampling methods for monitoring changes in gonococcal populations.

Authors:  K M Bindayna; C A Ison
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

2.  Self-Medication with Antibiotics among People Dwelling in Rural Areas of Sindh.

Authors:  Muhammad Bilal; Abdul Haseeb; Mohammad Hassaan Khan; Mohammad Hussham Arshad; Asma Akbar Ladak; Sufyan Khan Niazi; Muhammad Daniyal Musharraf; Adil Al-Karim Manji
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  [Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones].

Authors:  H C Korting; A Lukacs
Journal:  Infection       Date:  1989       Impact factor: 3.553

4.  Single dose cefoxitin in treating uncomplicated gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.

Authors:  K B Lim; T Thirumoorthy; C T Lee; S N Tham; E H Sng; T Tan
Journal:  Genitourin Med       Date:  1986-08

5.  In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda.

Authors:  J Bogaerts; J Vandepitte; E Van Dyck; R Vanhoof; M Dekegel; P Piot
Journal:  Genitourin Med       Date:  1986-08

6.  The roles of sexual and asexual gene transfer in emergence of antibiotic resistant gonococci.

Authors:  P F Sparling
Journal:  Trans Am Clin Climatol Assoc       Date:  1986

7.  Efficacy of NY-198 against experimental Legionnaires disease.

Authors:  S Kohno; K Yamaguchi; Y Dohtsu; H Koga; T Hayashi; M Hirota; A Saito; K Hara
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

8.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae: a trial organised as part of the United Kingdom national external quality assessment scheme for microbiology.

Authors:  J J Snell; D F Brown
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

9.  In vitro antimicrobial susceptibility of penicillinase-producing and intrinsically resistant Neisseria gonorrhoeae strains.

Authors:  M S Cohen; M H Cooney; E Blackman; P F Sparling
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

10.  Control of sexually transmitted diseases: view from the United States of America.

Authors:  W Cates; W C Parra; S T Brown
Journal:  Br J Vener Dis       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.